SOURCE: Proteonomix


May 24, 2010 09:15 ET

Proteonomix, Inc. (PROT) Announces Its Subsidiary Proteoderm, Inc. Commences Operation of Retail Web Site --

Proteoderm Will Be Accepting Pre-Orders, for Revolutionary Cosmetic Product on Monday, May 24, 2010

MOUNTAINSIDE, NJ--(Marketwire - May 24, 2010) -  Proteoderm, Inc. a subsidiary of Proteonomix, Inc. (PINKSHEETS: PROT) opened its retail web site,, and began accepting pre-orders for its anti-aging line of skin care products, Proteoderm. Proteoderm was unveiled to the public at the 2008 Session of the 16th Annual Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies. The response to the product was far beyond the Company's initial expectations. Subsequently, Proteonomix, Inc. received global interest for distribution of its anti-aging product Proteoderm; Proteoderm contains Matrix NC-138 an anti-aging bioactive ingredient, developed by Proteonomix Inc. Matrix NC-138 is the first product in the Company's pipeline that was a result of the Company's R & D program stem cell and collagen growth.

Due to the unexpected interest in Proteoderm, the Company has decided to open its retail sales utilizing pre-orders, on its subsidiary's website. The company has taken this action in order to further gauge demand, and to assist the company in managing its production and inventory levels.

Individuals ordering Proteoderm as a pre-order will not be billed for the product until it is shipped.  A firm shipment date will be announced in the future.

To learn more about Proteoderm, or to pre-order product, please visit

Certain statements contained herein are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that the statements made in this press release relating to Proteoderm constitute forward-looking statements and makes no guarantees of future performance and actual results or developments may differ materially from projections in forward-looking statements. Forward-looking statements are based on estimates and opinions of management at time the statements are made.

Contact Information

  • Contact:
    Michael Cohen
    Proteonomix, Inc.
    (973) 544-6116